// App-Quantinova.ai

4535 : The prognostic role of nephrectomy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with immunotherapy according to the novel prognostic Meet-URO score Subanalysis of the Meet-URO 15 study.

Researchers

Presenter

  • Sara Elena Rebuzzi

Principal Investigators

  • Giuseppe Luigi L. Banna

  • Sebastiano Buti

  • Pasquale Rescigno

  • Maria Gemelli

  • Stefano Panni

  • Francesco Massari

  • Mariella Sorarù

  • Matteo Santoni

  • Alessio Cortellini

  • Veronica Prati

  • Hector Josè Soto Parra

  • Francesco Atzori

  • Marilena Di Napoli

  • Orazio Caffo

  • Marco Messina

  • Franco Morelli

  • Giuseppe Prati

  • Giuseppe Fornarini

Medical Centers

  • Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova

  • Medical Oncology, Ospedale San Paolo, Milan, Italy

  • Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, Genoa, Italy

  • Candiolo Cancer Institue - FPO, IRCCS, Turin, Italy

  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy, Department of Medicine and Surgery, University of Parma, Parma, Italy

  • Medical Oncology Unit, IRCCS MultiMedica, Milan, Italy

  • Medical Oncology Unit, ASST-Istituti Ospitalieri Cremona Hospital, Cremona, Italy

  • Medical Oncology, Camposampiero Hospital, Camposampiero, Italy

  • Medical Oncology Unit, Macerata General Hospital, Macerata, Italy

  • Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Hammersmith Hospital, London, United Kingdom

  • Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, London, United Kingdom

  • Department of Medical Oncology, Ospedale S. Lazzaro Azienda Sanitaria Locale CN2, Alba-Bra, Cuneo, Italy

  • Department of Oncology, Medical Oncology, University Hospital Policlinico-San Marco, Catania, Italy

  • Medical Oncology Department, University Hospital, University of Cagliari, Cagliari, Italy

  • Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy

  • Presidio Ospedaliero Santa Chiara di Trento, APSS Trento, Trento, Italy

  • Medical Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy

  • Medical Oncology Department, IRCCS Casa Sollievo Della Sofferenza Hospital, San Giovanni Rotondo, Italy

  • Department of Oncology and Advanced Technologies, Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

  • Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Metastatic Renal Cell Cancer

Biomarkers

  • Neutrophil lymphocyte ratio

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved